Simulations Plus Equity 2025

Simulations Plus Aktienanalyse

What does Simulations Plus do?

Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Simulations Plus's Equity

Simulations Plus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Simulations Plus's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Simulations Plus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Simulations Plus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Simulations Plus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Simulations Plus stock

What is the equity of Simulations Plus this year?

Simulations Plus has equity of 182.43 M USD this year.

What was the equity of Simulations Plus compared to the previous year?

The equity of Simulations Plus has increased/decreased by 7.31% increased compared to the previous year.

What impact does a high equity have on investors of Simulations Plus?

A high equity is advantageous for investors of Simulations Plus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Simulations Plus?

A low equity can be a risk for investors of Simulations Plus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Simulations Plus affect the company?

An increase in equity of Simulations Plus can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Simulations Plus affect the company?

A reduction in equity of Simulations Plus can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Simulations Plus?

Some factors that can affect the equity of Simulations Plus include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Simulations Plus so important for investors?

The equity of Simulations Plus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Simulations Plus take to change the equity?

To change equity, Simulations Plus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Simulations Plus pay?

Over the past 12 months, Simulations Plus paid a dividend of 0.24 USD . This corresponds to a dividend yield of about 1.61 %. For the coming 12 months, Simulations Plus is expected to pay a dividend of 0.19 USD.

What is the dividend yield of Simulations Plus?

The current dividend yield of Simulations Plus is 1.61 %.

When does Simulations Plus pay dividends?

Simulations Plus pays a quarterly dividend. This is distributed in the months of November, March, May, August.

How secure is the dividend of Simulations Plus?

Simulations Plus paid dividends every year for the past 0 years.

What is the dividend of Simulations Plus?

For the upcoming 12 months, dividends amounting to 0.19 USD are expected. This corresponds to a dividend yield of 1.28 %.

In which sector is Simulations Plus located?

Simulations Plus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Simulations Plus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Simulations Plus from 8/5/2024 amounting to 0.06 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did Simulations Plus pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Simulations Plus in the year 2024?

In the year 2024, Simulations Plus distributed 0.24 USD as dividends.

In which currency does Simulations Plus pay out the dividend?

The dividends of Simulations Plus are distributed in USD.